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Abstract
Background/Aims—Evidence is unclear whether prenatal smoking affects age at menarche and 
pubertal development, and its impact upon hormones has not been well studied. We aim to 
identify potential pathways through which prenatal smoking and environmental tobacco smoke 
(ETS) affect reproductive hormones in girls approaching puberty.
Methods—We examined the association between prenatal smoking, current ETS and luteinizing 
hormone (LH) and inhibin B (InB) in 6-11-year-old girls in the 3rd National Health and Nutrition 
Examination Survey, 1988-1994. Parents/guardians completed interviewer-assisted questionnaires 
on health and demographics at the time of physical examination. Residual blood samples were 
analyzed for reproductive hormones in 2008.
Results—Of 660 girls, 19% and 39% were exposed to prenatal smoke and current ETS, 
respectively. Accounting for multiple pathways in structural equation models, prenatally exposed 
girls had significantly lower LH (ß=-0.205 log-mIU/mL, p<0.0001) and InB (ß=-0.162, log-
pg/mL, p<0.0001). Prenatal smoking also influenced LH positively and InB negatively indirectly 
through BMI-for-age. ETS was positively associated with LH, but not with InB.
Conclusion—Exposure to maternal smoking may disrupt reproductive development manifesting 
in altered hormone levels near puberty.
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INTRODUCTION
Maternal smoking is known to be detrimental to fetal growth and development [1], and long-
term effects on offspring have been documented for reduced fecundity [2] and chronic 
diseases [3]. Even so, rates of maternal smoking during pregnancy remain between 10 and 
20% in the United States [4]. The concept of early origins of disease has received increasing 
attention in the last decade with regard to in utero exposures and risk of childhood and 
adult-onset disease [5]. However, few studies have addressed early life factors associated 
with pubertal development and reproductive hormones, even though age at onset of pubertal 
development is recognized as a proxy of the reproductive health of a population [6].
Environmental factors have been found to effect changes in the onset of puberty [7], 
highlighting the importance of environmental endocrine disruptors in influencing 
reproductive development. Identifying factors that influence pubertal development is 
important at the population level because age at puberty is associated with age at debut of 
sexual activity, alcohol and drug use, depression, fragility fractures and risk of chronic 
disease [8-10]. Further, age at menarche has been associated most notably with breast cancer 
[11], but may simply be an early marker of chronic estrogen exposure, endocrine disruption 
and/or reproductive dysfunction.
Only a few studies have examined maternal smoking in relation to pubertal development and 
the results are conflicting [12-19]. Moreover, most studies were restricted to age at 
menarche, which occurs relatively late in the course of pubertal development and may be an 
insensitive indicator of pubertal onset. Individual assays of reproductive hormones may add 
new insight into the specific endocrine disruption associated with prenatal exposure to 
tobacco smoke, and the mechanisms by which early-life exposures affect reproductive 
development. Recent work suggests that InB and LH hormone concentrations are consistent 
with onset of puberty as indicated by Tanner breast stage 2 and rise progressively through 
the pubertal stages in this population of young girls (age 8-to-11 years) [20]. Inhibin B (InB) 
is produced by granulosa cells in the ovary paralleling development of ovarian follicles and 
is found to increase as girls approach puberty from 5 to 12 years of age [21, 22] whilst 
luteinizing hormone (LH) has long been recognized as important in the regulation of the 
hypothalamic-pituitary-gonadal axis and as a marker of pubertal development [22, 23]. 
However, previous population-based studies have not focused on hormonal markers of 
pubertal development.
We aimed to extend existing literature on age at menarche by measuring hormonal markers 
of early pubertal development that may be affected by environmental endocrine disruptors in 
a nationally-representative population of U.S. girls. We sought to answer the following 
research question: which potential pathways are important in linking prenatal smoking and 
current ETS with reproductive hormones in young girls? To answer this question, InB and 
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LH were chosen because of their patterns in younger children and likelihood of detection in 
those approaching puberty.
MATERIALS AND METHODS
We used data from girls aged 6-11 years who participated in the Third National Health and 
Nutrition Examination Survey (NHANES III), 1988-1994. In brief, NHANES III is a cross-
sectional nationally-representative study with a clustered, probability-sampling design. Non-
Hispanic Blacks and Mexican-Americans were oversampled to provide more precise 
estimates for these groups, and children were sampled into the following age categories: <6, 
6-11, 12-19 years. Details of the study design and data collection methods have been 
published elsewhere [24]. Youth participants (< 12 years) consented by proxy before 
participating in NHANES III. IRB approval was obtained through the National Center for 
Health Statistics.
We included 705 (44%) of the 1,589 girls aged 6-11 years who participated in the household 
interview, had a physical examination [24], and had residual stored blood for laboratory 
analysis. The main exposures were tobacco smoke in utero and current environmental 
tobacco smoke (ETS). During the NHANES III interview, mothers reported if they had 
smoked while pregnant with the child enrolled and if they smoked throughout the entire 
pregnancy or during what pregnancy month they quit. The protocol did not include asking 
the number of cigarettes smoked per day. For assessment of ETS, mothers reported the 
number of cigarette smokers who currently live in the child's home. We excluded two girls 
who reported being active smokers from the main analyses.
Sociodemographic variables of interest were available from the NHANES III database and 
included race/ethnicity, census region, metropolitan/non-metropolitan residence, and the 
poverty-income ratio (PIR). Based on the PIR distribution (range 0 to 6.9; median=1.3), we 
categorized PIR in approximate tertiles as <1, 1-2, and >2, so that a higher PIR indicates 
better household financial status. Anthropometric measurements (height, waist 
circumference, body mass index (BMI, kg/m2; z-score for age and raw value)) were also 
considered as potential confounders. We assessed whether adjustment for timing of the 
blood draw (morning, afternoon, evening) altered the association between smoke exposure 
and found this was not so. Additional confounding and potential mediator variables that 
were considered were maternal age at child's birth, weekly exercise, self-reported general 
health status of the child (5-point scale), and birthweight as reported by the mother.
Laboratory analysis
The laboratory assays for this project have been previously described in detail [25]. In brief, 
hormonal assays (InB and LH) were performed on non-fasting serum samples that were 
stored at -70° C and were obtained from the National Center for Health Statistics/Centers for 
Disease Control and Prevention by Rules-Based Medicine, Inc. Blood was drawn at the time 
of clinical examination according to the NHANES III protocol and categorized as to the 
timing of blood draw (morning, 8am-12pm; afternoon, 12pm-4pm; and evening, 4pm-7pm).
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Specifically, InB was measured using the DSL-10-84100 ACTIVE® Inhibin B ELISA assay 
(Gen I assay) [26]. The functional sensitivity was a priori set at 7 pg/ml (i.e., limit of 
detection (LOD)) per the manufacturer instructions. LH was measured using the LH ELISA 
kit (Bio-Quant BQ049F), a solid phase direct sandwich method. The LOD was set at 0.05 
mIU/mL and values below these levels were uniformly substituted with 0.035 mIU/mL, 
equivalent to LOD/√2. We used the continuous form of each hormone variable to avoid any 
assumptions concerning puberty-related hormone thresholds and the known inter-individual 
and intra-individual variation in hormone concentrations.
Statistical Methods
We categorized in utero exposure to smoking dichotomously (yes/no) and categorized 
current ETS exposure by number of smokers in the home (0, 1, and 2+). Both descriptive 
and analytic techniques were used to inspect and assess the data for the 705 girls with 
complete LH hormone measurements, and of these, 689 (98%) had complete inhibin B 
analysis. We created newly derived inverse probability sampling weights [27] to account for 
NHANES III's complex sampling design and the limited sera available for hormone 
analyses. Data management was conducted with SAS v9.3 (SAS, Cary, NC, USA) and 
Structural Equation Models were built using Analysis of Moment Structures software 
(AMOS, IBM-SPSS, Chicago, IL, USA).
Structural Equation Modeling
We used recursive Structural Equation Modeling (SEM) to examine hypothesized causal 
relations between observed and unobserved/latent variables with comprehensive modeling 
measurement errors [28]. This approach is well-suited for our research question – an 
environmental risk factor and later biological outcome [29] and the left censored hormone 
data available. We also explored the SEMs’ ability to model latent effects to address the 
LOD problem with hormone measures. As a result, the LOD was modeled as a latent factor 
in all SEMs while accommodating data challenges associated with environmental 
epidemiological data [30]. Bayesian SEM techniques were utilized to obtain robust 
estimation of pathway parameters while handling both categorical and continuous variables 
efficiently [31, 32].
We a priori identified potential SEM directional pathways predictive of puberty and 
hormone levels based on prior literature [14] and aimed to keep models as parsimonious as 
possible. Primary pathways are presented in Figure 1, including direct pathways between 
each smoking exposure to the hormones or indirectly affecting birthweight and later body 
size. For conceptual reasons, we also examined the joint effects of maternal smoking and 
ETS using an interaction term of maternal smoking*ETS as a separate pathway, as mothers 
who smoke during pregnancy may be more likely to continue smoking postnatally and/or 
live with other smokers.
Statistical significance of free parameters was formally tested using regression estimates to 
be different from zero with two-sided p-values (<0.05). We also accounted for both 
observed and unobserved confounders through alternate structural pathways operating 
Gollenberg et al. Page 4
Horm Res Paediatr. Author manuscript; available in PMC 2016 January 24.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
distally to influence hormone levels. They included PIR, sampling region, race/ethnicity, 
maternal age, child's age at blood draw, and general health status.
Several sensitivity analyses were conducted. To assess the effect of ETS alone on hormones, 
we constructed an SEM among only girls who were unexposed to tobacco in utero (n=556). 
We also ran the full analysis after excluding the small group of menarcheal girls (n=33) due 
to potential hormonal variations.
RESULTS
Approximately 19% (n=126) of girls were exposed to maternal smoking in utero. Of these, 
95 (75%) girls were exposed to maternal smoking throughout the pregnancy, whereas 31 
girls (25%) were exposed during part of the pregnancy. A rather high proportion of girls 
were currently exposed to ETS in the home by maternal report of 1+ smokers living with the 
child (40%), and of these, 100 (15%) girls were exposed to both in utero tobacco smoke and 
ETS.
Table 1 displays characteristics of participants by maternal smoking status. Most maternal 
and child characteristics were not significantly associated with exposure to maternal 
smoking. A few factors were significant (p<0.01): race/ethnicity, number of smokers in the 
house, maternal age, geographic region and weekly exercise. In terms of anthropometry, 
girls exposed to maternal smoke had greater waist circumferences (p=0.006) and were more 
often low birthweight (10.6% vs. 7.7%, non-significant) than those unexposed. Further, this 
subset of 6-to-11-year-old girls from NHANES III with stored sera was compared to the full 
NHANES III sample with regard to sociodemographics, hematologic and anthropometric 
measurements [25]. As described previously, few statistically significant differences were 
noted between the NHANES III sample with stored sera and those without. The noted 
exceptions were fewer non-Hispanic white girls and a slightly younger age by 4 months in 
this analytic sample. These differences were expected to occur by chance due to limited 
availability of sera.
The SEM estimates are displayed in Table 2 as they relate to LH specifically. We found that 
maternal smoking exposure was associated with decreased LH (p<0.0001.), after accounting 
for confounders, mediators, and unobserved error, whereas current ETS exposure was 
positively associated with LH (p<0.0001) with a negative interaction term (maternal 
smoking x ETS: p<0.0001). Further, maternal smoking was also significantly associated 
with LH indirectly through the BMI-for-age pathway; maternal smoking was associated with 
increased BMI-for-age and this in turn was associated with increased LH (Table 2). 
Maternal smoking was negatively associated with birth weight by approximately 150g 
(p<0.0001; data not shown) and the child's age (months) at blood draw was positively 
associated with LH (p<0.0001). Finally, when the model was restricted to girls who were not 
exposed to tobacco smoke in utero, ETS still remained significantly positively associated 
with LH (data not shown).
When examining the relationship between maternal smoking, ETS exposure and inhibin B, a 
similar result was observed (Table 3). In the presence of a statistically significant interaction 
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term of maternal smoking*ETS (p<0.0001), maternal smoking was associated with 
decreased InB (p<0.0001), whereas ETS was not associated with inhibin B (Table 3). In 
addition, a statistically significant indirect pathway was observed through which maternal 
smoking was significantly associated with InB indirectly through BMI-for-age. More 
specifically, maternal smoking was associated with increased BMI-for-age (p<0.0001) and 
BMI-for-age was significantly associated with decreased InB (p<0.0001). Finally, in the 
sensitivity analysis among only girls not exposed to tobacco smoke in utero, ETS was not 
significantly associated with InB.
When the SEMs were run among only pre-menarcheal girls, results remained robust and did 
not significantly change in direction, magnitude, or statistical significance.
DISCUSSION
We observed a negative association between exposure to maternal smoking and LH and InB 
concentrations in 6-to-11-year-old girls, whereas current ETS exposure was associated with 
increased LH, but not InB directly or indirectly. The differential timing of exposure across 
sensitive developmental windows between maternal smoking and childhood ETS may be a 
major contributing factor to the resultant effects on hormone measures, with in utero 
exposure potentially more harmful to reproductive development. The statistically significant 
interaction terms of maternal smoking*ETS exposure may suggest an adaptive effect of dual 
exposures on reproductive development, and thus requires further examination in a 
longitudinal context. A decrease in inhibin B, a marker of ovarian follicle development [22], 
and the gonadotropin LH, may suggest altered endocrine function that should be considered 
in the context of potential long-term chronic disease and reproductive function. This is the 
first study to examine this association with hormonal biomarkers for hypothalamic-pituitary-
gonadal activation in young girls near the onset of puberty and to account for multiple 
pathways. Our study represents a moderately large, nationally-representative sample of 
racially diverse girls in comparison to previous studies.
Few previous studies have examined maternal smoking in relation to pubertal development, 
and the majority was limited to an outcome of age at menarche. Factors that affect pubertal 
onset and endocrine function may not operate under the same mechanisms as factors that 
affect the rate at which girls mature through the successive pubertal stages. Further, we 
sought to ask a different question: what is the relationship between maternal smoking, ETS 
and reproductive hormone concentrations, rather than age at menarche. Results were 
conflicting amongst the existing menarche studies. Of the six studies that examined maternal 
smoking and age at menarche, three studies found an earlier age at menarche [13, 15, 16], 
two found a later age at menarche [17, 18], and one found no association [19] when 
comparing exposed vs. unexposed. Two studies originating from the AVON Longitudinal 
Study measured pubertal development based on self-reported Tanner stages in girls age 8-14 
years and found an earlier pubertal development in girls exposed to third trimester maternal 
smoking compared to the unexposed [12, 14]. Finally, the only study to measure the 
association between maternal smoking and reproductive hormones did so among a smaller 
cross-sectional sample (n=213) of 14-to-17 year-olds [33]. These authors found no 
associations between maternal smoking and anti-Mullerian hormone, inhibin B, and FSH, 
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though daughters exposed to maternal smoking had significantly smaller uterine volumes 
[33]. Furthermore, there are sparse data examining ETS exposure in childhood and pubertal 
development.
Many of the thousands of chemicals found in tobacco smoke, including metals, pesticides 
and polyaromatic hydrocarbons, have been found to be anti-estrogenic [34] and more 
recently, found to affect progesterone and gonadotropins in premenopausal women, with 
effects differing by hormone and phase of the menstrual cycle [35]. Our study extends this 
knowledge by using SEMs to demonstrate that maternal smoking is structurally associated 
with altered hormone levels in young girls. While we are not able to determine the exact 
biologic mechanism by which tobacco smoke in utero may disrupt endocrine regulation, this 
study adds to prior literature by being among the first to demonstrate multiple pathways by 
which maternal smoking and its mediators may modify reproductive development. We 
hypothesize that in utero exposure to tobacco smoke may alter reproductive hormone levels, 
but the observed changes may not fully manifest until puberty approaches or even later, as 
other studies have observed with different, adverse early-life exposures [36-38].
There have been few studies to examine the association between childhood ETS exposure 
and pubertal development. The few studies that have examined ETS exposure and age at 
menarche did not observe a robust association [15, 18], though one study did observe a 
synergistic effect of both maternal exposure and childhood ETS exposure on a later age at 
menarche [18]. To date we could not identify a study that has examined both current ETS 
and reproductive hormones in this age group. More research is needed to elucidate the 
effects of ETS on reproductive development in young girls.
Our observation that maternal smoking may influence inhibin B and LH levels indirectly 
through BMI warrants further investigation. It has been documented that in utero exposure 
to tobacco smoke influences early childhood growth, most often evidenced by a decrease in 
birthweight and a later increase in weight gain and child BMI [39]. In addition, it has been 
reported that girls with greater BMI often experience earlier age at menarche, a late-stage 
pubertal event [18, 19]. However, it remains unclear if girls with greater childhood BMI 
develop breast changes as a consequence of mild increases in estrogen stimulation, actually 
enter puberty earlier as defined by increased hypothalamic-pituitary-ovarian activity, or 
instead, progress through the pubertal stages quicker thereby experiencing the late-stage 
pubertal event, menarche, earlier [40]. Our results may suggest that a greater BMI at age 
6-11 years of age is inversely associated with inhibin B levels (Table 3) but positively 
associated with LH levels (Table 2) and this contrasting effect has been observed in adult 
fertile women and those with polycystic ovarian syndrome [41, 42]. Therefore, the 
relationship between maternal smoking and child growth and adiposity may differentially 
influence reproductive development as manifested through LH and inhibin B pathways.
We employed a robust SEM approach which precluded our models from relying on an a 
priori assumption of linear association structure, but instead to examine both direct and 
indirect pathways through which primary exposures may be associated with pubertal 
hormones. SEMs connect all covariates by their moments for the estimation of associations, 
with explicit regard for the time sequence; unlike multiple regression techniques [30] which 
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assume these periods/covariates occur concurrently and also cannot adequately address 
mediated pathways. Our use of SEMs is largely hypothesis-generating; however, the SEMs 
are based on a sound conceptual framework and have been applied in multiple fields [29].
Our results should be interpreted in light of the limitations inherent in the cross-sectional 
design of NHANES III and the methods of ascertaining prenatal smoking and ETS 
exposure. Mothers were asked to report whether they smoked during the pregnancy with the 
index child and the child's birth weight and this recall may have extended 6 to 11 years. Any 
misclassification of in utero smoke exposure or birth weight due to inaccurate maternal 
recall, however, would most likely be random and not related to the daughter's hormone 
levels. ETS exposure was also determined by parental self-report; however, previous 
validation studies have shown that parents in NHANES III are generally accurate in 
reporting child's ETS exposure as validated against cotinine measurements [43]. In addition, 
dose of cigarettes per day was not collected and precluded our ability to assess dose-
response associations.
CONCLUSION
In summary, we found maternal smoking was negatively associated with LH and InB, and 
the effect was modified by the presence of current ETS exposure. Experimental and 
epidemiologic evidence suggests biologic plausibility for the endocrine disrupting properties 
of maternal smoking. Further research should extend the hormone analyses to later ages to 
relate in utero exposures and ETS to hormones, timing of secondary sexual characteristics, 
and age at menarche. Longitudinal studies that incorporate multiple hormone measurements 
tracking children as they approach and progress through pubertal stages will add further 
insight into the biological mechanisms linking maternal smoking and ETS to endocrine 
disruption in adolescents [6].
Acknowledgments
Funding
Laboratory analyses completed with intramural support from the Eunice Kennedy Shriver National Institute of 
Child Health & Human Development/National Institutes of Health
Reference List
1. Naeye RL. Influence of maternal cigarette smoking during pregnancy on fetal and childhood 
growth. Obstet Gynecol. 1981; 57:18–21. [Published online first 1981/01/01]. [PubMed: 7454172] 
2. Jensen TK, Henriksen TB, Hjollund NH, Scheike T, Kolstad H, Giwercman A, Ernst E, Bonde JP, 
Skakkebaek NE, Olsen J. Adult and prenatal exposures to tobacco smoke as risk indicators of 
fertility among 430 Danish couples. Am J Epidemiol. 1998; 148:992–7. [Published online first 
1998/11/26]. [PubMed: 9829871] 
3. Doherty SP, Grabowski J, Hoffman C, Ng SP, Zelikoff JT. Early life insult from cigarette smoke 
may be predictive of chronic diseases later in life. Biomarkers. 2009; 14(Suppl 1):97–101. 
10.1080/13547500902965898 [Published online first 2009/10/22]. [PubMed: 19604068] 
4. Anderka M, Romitti PA, Sun L, Druschel C, Carmichael S, Shaw G, National Birth Defects 
Prevention Study. Patterns of tobacco exposure before and during pregnancy. Acta Obstet Gynecol 
Scand. 2010; 89:505–14. 10.3109/00016341003692261 [Published online first 2010/04/07]. 
[PubMed: 20367429] 
Gollenberg et al. Page 8
Horm Res Paediatr. Author manuscript; available in PMC 2016 January 24.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
5. Barouki R, Gluckman PD, Grandjean P, Hanson M, Heindel JJ. Developmental origins of 
noncommunicable disease: implications for research and public health. Environ Health. 2012; 
11:42. 10.1186/1476-069x-11-42 [Published online first 2012/06/22]. [PubMed: 22715989] 
6. Buck Louis GM, Gray LE Jr. Marcus M, Ojeda SR, Pescovitz OH, Witchel SF, Sippell W, Abbott 
DH, Soto A, Tyl RW, Bourguignon JP, Skakkebaek NE, Swan SH, Golub MS, Wabitsch M, 
Toppari J, Euling SY. Environmental factors and puberty timing: expert panel research needs. 
Pediatrics. 2008; 121(Suppl 3):S192–207. 10.1542/peds.1813E [Published online first 2008/02/15]. 
[PubMed: 18245512] 
7. Euling SY, Selevan SG, Pescovitz OH, Skakkebaek NE. Role of environmental factors in the timing 
of puberty. Pediatrics. 2008; 121(Suppl 3):S167–71. 10.1542/peds.2007-1813C [Published online 
first 2008/02/15]. [PubMed: 18245510] 
8. Chevalley T, Bonjour JP, Ferrari S, Rizzoli R. The influence of pubertal timing on bone mass 
acquisition: a predetermined trajectory detectable five years before menarche. J Clin Endocrinol 
Metab. 2009; 94:3424–31. 10.1210/jc.2009-0241 [Published online first 2009/06/18]. [PubMed: 
19531591] 
9. Hayatbakhsh MR, Najman JM, McGee TR, Bor W, O'Callaghan MJ. Early pubertal maturation in 
the prediction of early adult substance use: a prospective study. Addiction. 2009; 104:59–66. 
10.1111/j.1360-0443.2008.02382.x [Published online first 2008/11/06]. [PubMed: 18983626] 
10. Golub MS, Collman GW, Foster PM, Kimmel CA, Rajpert-De Meyts E, Reiter EO, Sharpe RM, 
Skakkebaek NE, Toppari J. Public health implications of altered puberty timing. Pediatrics. 2008; 
121(Suppl 3):S218–30. 10.1542/peds.2007-1813G [Published online first 2008/02/15]. [PubMed: 
18245514] 
11. Opdahl S, Alsaker MD, Janszky I, Romundstad PRVatten LJ. Joint effects of nulliparity and other 
breast cancer risk factors. Br J Cancer. 2011; 105:731–6. 10.1038/bjc.2011.286 [Published online 
first 2011/08/04]. [PubMed: 21811252] 
12. Maisonet M, Christensen KY, Rubin C, Holmes A, Flanders WD, Heron J, Ong KK, Golding J, 
McGeehin MA, Marcus M. Role of prenatal characteristics and early growth on pubertal 
attainment of British girls. Pediatrics. 2010; 126:e591–600. 10.1542/peds.2009-2636 [Published 
online first 2010/08/11]. [PubMed: 20696722] 
13. Morris DH, Jones ME, Schoemaker MJ, Ashworth A, Swerdlow AJ. Determinants of age at 
menarche in the UK: analyses from the Breakthrough Generations Study. Br J Cancer. 2010; 
103:1760–4. 10.1038/sj.bjc.6605978 [Published online first 2010/11/04]. [PubMed: 21045834] 
14. Rubin C, Maisonet M, Kieszak S, Monteilh C, Holmes A, Flanders D, Heron J, Golding J, 
McGeehin M, Marcus M. Timing of maturation and predictors of menarche in girls enrolled in a 
contemporary British cohort. Paediatr Perinat Epidemiol. 2009; 23:492–504. 10.1111/j.
1365-3016.2009.01055.x [Published online first 2009/08/20]. [PubMed: 19689500] 
15. Shrestha A, Nohr EA, Bech BH, Ramlau-Hansen CH, Olsen J. Smoking and alcohol use during 
pregnancy and age of menarche in daughters. Hum Reprod. 2011; 26:259–65. 10.1093/humrep/
deq316 [Published online first 2010/11/26]. [PubMed: 21098623] 
16. Windham GC, Bottomley C, Birner C, Fenster L. Age at menarche in relation to maternal use of 
tobacco, alcohol, coffee, and tea during pregnancy. Am J Epidemiol. 2004; 159:862–71. 
[Published online first 2004/04/24]. [PubMed: 15105179] 
17. Windham GC, Zhang L, Longnecker MP, Klebanoff M. Maternal smoking, demographic and 
lifestyle factors in relation to daughter's age at menarche. Paediatr Perinat Epidemiol. 2008; 
22:551–61. 10.1111/j.1365-3016.2008.00948.x [Published online first 2008/11/13]. [PubMed: 
19000293] 
18. Ferris JS, Flom JD, Tehranifar P, Mayne ST, Terry MB. Prenatal and childhood environmental 
tobacco smoke exposure and age at menarche. Paediatr Perinat Epidemiol. 2010; 24:515–23. 
10.1111/j.1365-3016.2010.01154.x [Published online first 2010/10/20]. [PubMed: 20955229] 
19. Terry MB, Ferris JS, Tehranifar P, Wei Y, Flom JD. Birth weight, postnatal growth, and age at 
menarche. Am J Epidemiol. 2009; 170:72–9. 10.1093/aje/kwp095 [Published online first 
2009/05/15]. [PubMed: 19439580] 
20. Sims EK, Addo OY, Gollenberg AL, Himes JH, Hediger ML, Lee PA. Inhibin B and luteinizing 
hormone levels in girls aged 6-11 years from NHANES III, 1988-1994. Clin Endocrinol (Oxf). 
Gollenberg et al. Page 9
Horm Res Paediatr. Author manuscript; available in PMC 2016 January 24.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
2012; 77:555–63. 10.1111/j.1365-2265.2012.04393.x [Published online first 2012/03/27]. 
[PubMed: 22443272] 
21. Crofton PM, Evans AE, Groome NP, Taylor MR, Holland CV, Kelnar CJ. Dimeric inhibins in girls 
from birth to adulthood: relationship with age, pubertal stage, FSH and oestradiol. Clin Endocrinol 
(Oxf). 2002; 56:223–30. [Published online first 2002/03/05]. [PubMed: 11874414] 
22. Chada M, Prusa R, Bronsky J, Pechova M, Kotaska K, Lisa L. Inhibin B, follicle stimulating 
hormone, luteinizing hormone, and estradiol and their relationship to the regulation of follicle 
development in girls during childhood and puberty. Physiol Res. 2003; 52:341–6. [Published 
online first 2003/06/07]. [PubMed: 12790766] 
23. Teilmann G, Boas M, Petersen JH, Main KM, Gormsen M, Damgaard K, Brocks V, Skakkebaek 
NE, Jensen TK. Early pituitary-gonadal activation before clinical signs of puberty in 5- to 8-year-
old adopted girls: a study of 99 foreign adopted girls and 93 controls. J Clin Endocrinol Metab. 
2007; 92:2538–44. 10.1210/jc.2006-2096 [Published online first 2007/05/03]. [PubMed: 
17473073] 
24. National Center for Health Statistics. Plan and Operation of the Third National Health and 
Nutrition Examination Survey, 1988-1994. Vol. Vital Health Stat 1. No. 32. US Department of 
Health and Human Services PHS 94-1308; Hyattsville, MD: 1994. 
25. Gollenberg AL, Hediger ML, Lee PA, Himes JH, Louis GM. Association between lead and 
cadmium and reproductive hormones in peripubertal U.S. girls. Environ Health Perspect. 2010; 
118:1782–7. 10.1289/ehp.1001943 [Published online first 2010/08/03]. [PubMed: 20675266] 
26. Ludlow H, Muttukrishna S, Hyvonen M, Groome NP. Development of a new antibody to the 
human inhibin/activin betaB subunit and its application to improved inhibin B ELISAs. J Immunol 
Methods. 2008; 329:102–11. 10.1016/j.jim.2007.09.013 [Published online first 2007/11/10]. 
[PubMed: 17991484] 
27. Robins J, Rotnitzky A, Zhao L. Estimation of regression coefficients when some regressors are not 
always observed. J Am Stat Assoc. 1994; 89:846–66. [Published online first. 
28. Budtz-Jorgensen E, Grandjean P, Weihe P, White R. Statistical methods for the evaluation of 
health effects of prenatal mercury exposure. Environmetrics. 2003; 14:105–20. [Published online 
first. 
29. Greenland S, Brumback B. An overview of relations among causal modelling methods. Int J 
Epidemiol. 2002; 31:1030–7. [Published online first 2002/11/19]. [PubMed: 12435780] 
30. Davis ME. Structural equation models in occupational health: an application to exposure 
modelling. Occup Environ Med. 2012; 69:184–90. 10.1136/oem.2010.063032 [Published online 
first 2011/06/18]. [PubMed: 21680563] 
31. Hu L, Bentler P. Cutoff criteria for fit indices in covariance structure analysis: Conventional 
criteria versus new alternatives structural equation modelling. A Multidisciplinary Journal. 1999; 
6:1–55. [Published online first. 
32. Nikolov MC, Coull BA, Catalano PJ, Godleski JJ. An informative Bayesian structural equation 
model to assess source-specific health effects of air pollution. Biostatistics. 2007; 8:609–24. 
10.1093/biostatistics/kxl032 [Published online first 2006/10/13]. [PubMed: 17032699] 
33. Hart R, Sloboda DM, Doherty DA, Norman RJ, Atkinson HC, Newnham JP, Dickinson JE, Hickey 
M. Prenatal determinants of uterine volume and ovarian reserve in adolescence. J Clin Endocrinol 
Metab. 2009; 94:4931–7. 10.1210/jc.2009-1342 [Published online first 2009/10/23]. [PubMed: 
19846735] 
34. Baron JA, La Vecchia C, Levi F. The antiestrogenic effect of cigarette smoking in women. Am J 
Obstet Gynecol. 1990; 162:502–14. [Published online first 1990/02/01]. [PubMed: 2178432] 
35. Windham GC, Mitchell P, Anderson M, Lasley BL. Cigarette smoking and effects on hormone 
function in premenopausal women. Environ Health Perspect. 2005; 113:1285–90. [Published 
online first 2005/10/06]. [PubMed: 16203235] 
36. Ibanez L, Potau N, de Zegher F. Ovarian hyporesponsiveness to follicle stimulating hormone in 
adolescent girls born small for gestational age. J Clin Endocrinol Metab. 2000; 85:2624–6. 
10.1210/jcem.85.7.6765 [Published online first 2000/07/21]. [PubMed: 10902818] 
Gollenberg et al. Page 10
Horm Res Paediatr. Author manuscript; available in PMC 2016 January 24.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
37. Ibanez L, Potau N, Enriquez G, de Zegher F. Reduced uterine and ovarian size in adolescent girls 
born small for gestational age. Pediatr Res. 2000; 47:575–7. [Published online first 2000/05/17]. 
[PubMed: 10813579] 
38. Ibanez L, Potau N, Enriquez G, Marcos MV, de Zegher F. Hypergonadotrophinaemia with reduced 
uterine and ovarian size in women born small-for-gestational-age. Hum Reprod. 2003; 18:1565–9. 
[Published online first 2003/07/23]. [PubMed: 12871863] 
39. Beyerlein A, Ruckinger S, Toschke AM, Schaffrath Rosario A, von Kries R. Is low birth weight in 
the causal pathway of the association between maternal smoking in pregnancy and higher BMI in 
the offspring? Eur J Epidemiol. 2011; 26:413–20. 10.1007/s10654-011-9560-y [Published online 
first 2011/03/02]. [PubMed: 21360298] 
40. Sorensen K, Mouritsen A, Aksglaede L, Hagen CP, Mogensen SS, Juul A. Recent secular trends in 
pubertal timing: implications for evaluation and diagnosis of precocious puberty. Horm Res 
Paediatr. 2012; 77:137–45. 10.1159/000336325 [Published online first 2012/04/18]. [PubMed: 
22508036] 
41. Cortet-Rudelli C, Pigny P, Decanter C, Leroy M, Maunoury-Lefebvre C, Thomas-Desrousseaux P, 
Dewailly D. Obesity and serum luteinizing hormone level have an independent and opposite effect 
on the serum inhibin B level in patients with polycystic ovary syndrome. Fertil Steril. 2002; 
77:281–7. [Published online first 2002/02/01]. [PubMed: 11821084] 
42. De Pergola G, Maldera S, Tartagni M, Pannacciulli N, Loverro G, Giorgino R. Inhibitory effect of 
obesity on gonadotropin, estradiol, and inhibin B levels in fertile women. Obesity (Silver Spring). 
2006; 14:1954–60. 10.1038/oby.2006.228 [Published online first 2006/12/01]. [PubMed: 
17135611] 
43. Wilkinson JD, Arheart KL, Lee DJ. Accuracy of parental reporting of secondhand smoke 
exposure: The National Health and Nutrition Examination Survey III. Nicotine Tob Res. 2006; 
8:591–7. 10.1080/14622200600790021 [Published online first 2006/08/22]. [PubMed: 16920657] 
Gollenberg et al. Page 11
Horm Res Paediatr. Author manuscript; available in PMC 2016 January 24.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
‘Established Facts’
• Environmental factors have been shown to influence age at onset of puberty in 
girls, and this phenomenon may explain, in part, secular changes in population-
based pubertal attainment.
• Maternal smoking has been explored in relation to pubertal development in 
girls, but results are conflicting with regard to the directionality of results.
‘Novel Insights’
• We observed that maternal smoking was negatively associated with 
reproductive hormones, luteinizing hormone and inhibin B, in 6-11 year-old 
girls after adjusting for multiple pathways by which early life factors may 
influence hormones and current exposure to environmental tobacco smoke.
• Early life tobacco smoke exposure may influence reproductive development as 
manifested by altered hormone levels in adolescence and should be considered 
in the context of life course epidemiology.
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Figure 1. 
BMI denotes body mass index
ETS denotes environmental tobacco smoke
LOD denotes limit of detection
PIR denotes poverty-income ratio
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Table 1
Participant Characteristics According to Maternal Smoking Exposure, NHANES III, 1988-1994
Exposure to Maternal Smoking No n (%) Yes n (%) P-valuec
534 (80.8) 127 (19.2)
Characteristics
Race/Ethnicity
White 100 (18.7) 45 (35.4) <0.001
Black 194 (36.3) 58 (45.7)
Mexican 240 (44.9) 24 (18.9)
Poverty-Income Ratio
<1 212 (39.7) 51 (40.2) 0.98
1-2 127 (23.8) 32 (25.2)
>2 156 (29.2) 35 (27.6)
Don't know 39 (7.3) 9 (7.1)
Sampling Region
Northeast 41 (7.7) 7 (5.5) 0.008
Midwest 110 (20.6) 40 (31.5)
South 206 (38.6) 54 (42.5)
West 177 (33.1) 26 (20.5)
Residence
Metropolitan 289 (54.1) 62 (48.8) 0.28
Non-metropolitan 245 (45.9) 65 (51.2)
Low Birthweight
No 471 (92.4) 110 (89.4) 0.29
Yes 39 (7.7) 13 (10.6)
Sweat during exercise: times per week
0-1 198 (37.1) 46 (36.2) 0.04
1-2 94 (17.6) 11 (8.6)
3-5 147 (27.5) 42 (33.1)
6 or more 95 (17.8) 28 (22.1)
General Health Rating
Good/Excellent 476 (89.1) 118 (92.9) 0.21
Fair/poor 58 (10.9) 9 (7.1)
Number of smokers in the household
0 374 (70.0) 27 (21.3) <0.0001
1 121 (22.7) 50 (39.4)
2+ 39 (7.3) 50 (39.4)
Ever smoked at least 1 cigarette
No 329 (97.1) 78 (95.1) 0.49
aYes 10 (2.9) 4 (4.9)
Age
Mean months (95% CI) 108.0 (106.2-109.7) 106.5 (102.9-110.1) 0.48
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Exposure to Maternal Smoking No n (%) Yes n (%) P-valuec
534 (80.8) 127 (19.2)
bBMI z-score for age
Mean (95% CI) 0.34 (0.24-0.44) 0.48 (0.29-0.67) 0.2
BMI value (kg/m2)
Mean (95% confidence interval) 18.0 (17.7-18.4) 18.6 (18.0-19.3) 0.13
Maternal age at birth
Mean (95% CI) 25.0 (24.5-25.5) 23.7 (22.7-24.8) 0.03
Height: z-score for age
Mean (95% CI) 0.31 (0.22-0.40) 0.29 (0.11-0.48) 0.88
Waist-to-height ratio
Mean (95% CI) 0.86 (0.85-0.86) 0.87 (0.86-0.88) 0.006
aOf the 14 who reported ever smoking at least 1 cigarette, only 2 individuals reported being a current smoker.
b
BMI denotes body mass index.
c
P-values calculated using the Chi-square test for categorical variables and t-tests for continuous variables.
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Table 2
Model 1: Primary Pathways for the Association between Maternal Smoking, Environmental Tobacco Smoke 
(ETS) and Luteinizing Hormone (LH) in Peripubertal Girls, NHANES III, 1988-1994.
Pathways Estimate S.E.a C.R.b P-value
Maternal smoking → LHc −.205 .014 −15.03 <0.0001
Maternal smoking → BMI-for-age zd .158 .027 5.72 <0.0001
ETS → LHc .056 .007 7.49 <0.0001
BMI-for-age z → LHc .035 .004 8.04 <0.0001
Maternal smoking*ETS → LHc −.039 .008 −4.64 <0.0001
Offspring Age → LHc .214 .003 75.95 <0.0001
aS.E. denotes standard error
bC.R. denotes critical ratio
c
LH estimates are in log-mIU/mL units.
d
BMI-for-age estimates are in z-score units
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Table 3
Model 2: Primary Pathways for the Association between Maternal Smoking, ETS and Inhibin B in 
Peripubertal Girls, NHANES III, 1988-1994.
Pathway Estimate S.E.a C.R.b P-value
Maternal smoking → Inhibin Bc −.162 .022 −7.260 <0.0001
Maternal smoking → BMI-for-age zd .157 .027 5.723 <0.0001
ETS → Inhibin Bc .007 .012 .567 .571
BMI-for-age z → Inhibin Bc −.098 .007 −13.642 <0.0001
Maternal smoking*ETS → Inhibin Bc .082 .014 5.972 <0.0001
Offspring Age → Inhibin Bc .156 .005 33.745 <0.0001
Footnotes:
aS.E. denotes standard error
bC.R. denotes critical ratio
c
Inhibin B estimates are in log-pg/mL units.
d
BMI-for-age estimates are in z-score units.
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